TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis

Cellular Immunology

Volumn 258, Issue 1, 2009, Pages 29-37

  Drage, Michael G ^a   Pecora, Nicole D ^a   Hise, Amy G ^a   Febbraio, Maria ^b   Silverstein, Roy L ^b   Golenbock, Douglas T ^c   Boom, W Henry ^d   Harding, Clifford V ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antigen presenting cell; CD14; CD36; Lipoprotein; Mycobacterium tuberculosis; Toll like receptor 2

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD36 ANTIGEN; GLYCOPROTEIN P 15095; LIPOPROTEIN; LIPOPROTEIN LPQH; LIPOPROTEIN LPRA; LIPOPROTEIN PHOS1; MYCOBACTERIUM TUBERCULOSIS LIPOPROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD14; ANTIGENS, CD36; CELL LINE; DENDRITIC CELLS; FEMALE; HUMANS; LIPOPROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

MYCOBACTERIUM TUBERCULOSIS;

EID: 67349217383     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.03.008     Document Type: Article

References (46)

1. Drennan M.B., Nicolle D., Quesniaux V.J., Jacobs M., Allie N., Mpagi J., Fremond C., Wagner H., Kirschning C., and Ryffel B. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am. J. Pathol. 164 (2004) 49-57
2. Bafica A., Scanga C.A., Feng C.G., Leifer C., Cheever A., and Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202 (2005) 1715-1724
3. Sugawara I., Yamada H., Li C., Mizuno S., Takeuchi O., and Akira S. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol. Immunol. 47 (2003) 327-336
4. Reiling N., Holscher C., Fehrenbach A., Kroger S., Kirschning C.J., Goyert S., and Ehlers S. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169 (2002) 3480-3484
5. Bochud P.Y., Hawn T.R., and Aderem A. Cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170 (2003) 3451-3454
6. Sutcliffe I.C., and Harrington D.J. Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components. FEMS Microbiol. Rev. 28 (2004) 645-659
7. Pecora N.D., Gehring A.J., Canaday D.H., Boom W.H., and Harding C.V. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J. Immunol. 177 (2006) 422-429
8. Gehring A.J., Dobos K.M., Belisle J.T., Harding C.V., and Boom W.H. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173 (2004) 2660-2668
9. Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T., Boom W.H., and Harding C.V. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19 kD lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167 (2001) 910-918
10. Pai R.K., Convery M., Hamilton T.A., Boom W.H., and Harding C.V. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 171 (2003) 175-184
11. Pai R.K., Pennini M.E., Tobian A.A., Canaday D.H., Boom W.H., and Harding C.V. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect. Immun. 72 (2004) 6603-6614
12. Jung S.B., Yang C.S., Lee J.S., Shin A.R., Jung S.S., Son J.W., Harding C.V., Kim H.J., Park J.K., Paik T.H., Song C.H., and Jo E.K. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infect. Immun. 74 (2006) 2686-2696
13. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., and Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169 (2002) 10-14
14. Tapping R.I., and Tobias P.S. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J. Endotoxin Res. 9 (2003) 264-268
15. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., and Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13 (2001) 933-940
16. Takeda K., Takeuchi O., and Akira S. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. 8 (2002) 459-463
17. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., and Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130 (2007) 1071-1082
18. Massari P., Visintin A., Gunawardana J., Halmen K.A., King C.A., Golenbock D.T., and Wetzler L.M. Meningococcal Porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 176 (2006) 2373-2380
19. Wang Q., McLoughlin R.M., Cobb B.A., Charrel-Dennis M., Zaleski K.J., Golenbock D., Tzianabos A.O., and Kasper D.L. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp. Med. 203 (2006) 2853-2863
20. Yamashita Y., Maeda Y., Takeshita F., Brennan P.J., and Makino M. Role of the polypeptide region of a 33 kDa mycobacterial lipoprotein for efficient IL-12 production. Cell. Immunol. 229 (2004) 13-20
21. VanderVen B.C., Harder J.D., Crick D.C., and Belisle J.T. Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways. Science 309 (2005) 941-943
22. Henneke P., Takeuchi O., van Strijp J.A., Guttormsen H.K., Smith J.A., Schromm A.B., Espevik T.A., Akira S., Nizet V., Kasper D.L., and Golenbock D.T. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J. Immunol. 167 (2001) 7069-7076
23. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zahringer U., and Beutler B. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
24. Schroder N.W., Heine H., Alexander C., Manukyan M., Eckert J., Hamann L., Gobel U.B., and Schumann R.R. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J. Immunol. 173 (2004) 2683-2691
25. Hajishengallis G., Ratti P., and Harokopakis E. Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors. J. Biol. Chem. 280 (2005) 38902-38913
26. Liang S., Wang M., Tapping R.I., Stepensky V., Nawar H.F., Triantafilou M., Triantafilou K., Connell T.D., and Hajishengallis G. Ganglioside GD1a is an essential coreceptor for Toll-like receptor 2 signaling in response to the B subunit of type IIb enterotoxin. J. Biol. Chem. 282 (2007) 7532-7542
27. Vasselon T., Detmers P.A., Charron D., and Haziot A. TLR2 recognizes a bacterial lipopeptide through direct binding. J. Immunol. 173 (2004) 7401-7405
28. Vasselon T., Hanlon W.A., Wright S.D., and Detmers P.A. Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38. J. Leukoc. Biol. 71 (2002) 503-510
29. Stuart L.M., Deng J., Silver J.M., Takahashi K., Tseng A.A., Hennessy E.J., Ezekowitz R.A., and Moore K.J. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170 (2005) 477-485
30. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., and Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 4 (2006) 211-221
31. Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R.T., Medzhitov R., Fikrig E., and Flavell R.A. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8 (2002) 878-884
32. Gonzalez-Juarrero M., Shim T.S., Kipnis A., Junqueira-Kipnis A.P., and Orme I.M. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J. Immunol. 171 (2003) 3128-3135
33. Reljic R., Di Sano C., Crawford C., Dieli F., Challacombe S., and Ivanyi J. Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis 85 (2005) 81-88
34. Humphreys I.R., Stewart G.R., Turner D.J., Patel J., Karamanou D., Snelgrove R.J., and Young D.B. A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect. 8 (2006) 1339-1346
35. Wolf A.J., Linas B., Trevejo-Nunez G.J., Kincaid E., Tamura T., Takatsu K., and Ernst J.D. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179 (2007) 2509-2519
36. Ashbridge K.R., Prestidge R.L., Booth R.J., and Watson J.D. The mapping of an antibody-binding region on the Mycobacterium tuberculosis 19 kilodalton antigen. J. Immunol. 144 (1990) 3137-3142
37. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., Sharma K., and Silverstein R.L. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105 (2000) 1049-1056
38. Sklar M.D., Tereba A., Chen B.D., and Walker W.S. Transformation of mouse bone marrow cells by transfection with a human oncogene related to c-myc is associated with the endogenous production of macrophage colony stimulating factor 1. J. Cell. Physiol. 125 (1985) 403-412
39. Flo T.H., Ryan L., Latz E., Takeuchi O., Monks B.G., Lien E., Halaas O., Akira S., Skjak-Braek G., Golenbock D.T., and Espevik T. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem. 277 (2002) 35489-35495
40. Latz E., Visintin A., Lien E., Fitzgerald K.A., Monks B.G., Kurt-Jones E.A., Golenbock D.T., and Espevik T. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277 (2002) 47834-47843
41. Pecora N.D., Fulton S.A., Reba S.M., Drage M.G., Simmons D.P., Urankar-Nagy N.J., Boom W.H., and Harding C.V. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cell. Immunol. 254 (2008) 94-104
42. Ordway D., Henao-Tamayo M., Orme I.M., and Gonzalez-Juarrero M. Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family. J. Immunol. 175 (2005) 3873-3881
43. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., and Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 (1999) 732-736
44. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., Akira S., and Ulmer A.J. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol. 35 (2005) 282-289
45. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108 (2001) 785-791
46. Triantafilou M., Gamper F.G., Haston R.M., Mouratis M.A., Morath S., Hartung T., and Triantafilou K. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281 (2006) 31002-31011